Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, ...18, 19, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-06-05
4:45 pm
Purchase
13GTScan Therapeutics, Inc.
TCRX
BIOTECHNOLOGY VALUE FUND L P4,414,910
9.99%
4,414,910increase
(New Position)
View
2023-05-30
4:45 pm
Purchase
13GJanux Therapeutics, Inc.
JANX
BIOTECHNOLOGY VALUE FUND L P4,106,945
9.8%
4,106,945increase
(New Position)
View
2023-05-22
4:47 pm
Purchase
13DPieris Pharmaceuticals, Inc.
PIRS
BIOTECHNOLOGY VALUE FUND L P20,609,863
22%
12,915,803increase
(+167.87%)
View
2023-03-24
4:33 pm
Purchase
13GIDEAYA Biosciences, Inc.
IDYA
BIOTECHNOLOGY VALUE FUND L P2,455,089
5.1%
250,000increase
(+11.34%)
View
2023-03-20
5:04 pm
Purchase
13GProtagonist Therapeutics, Inc.
PTGX
BIOTECHNOLOGY VALUE FUND L P5,025,900
9.6%
3,775,900increase
(+302.07%)
View
2023-03-16
4:48 pm
Purchase
13GAclaris Therapeutics, Inc.
ACRS
BIOTECHNOLOGY VALUE FUND L P3,360,941
5%
84,398increase
(+2.58%)
View
2023-03-06
5:10 pm
Purchase
13GASLAN Pharmaceuticals Limited
ASLN
BIOTECHNOLOGY VALUE FUND L P42,440,000
9.99%
42,440,000increase
(New Position)
View
2023-02-14
12:10 pm
Sale
13GMolecular Partners AG
MOLN
BIOTECHNOLOGY VALUE FUND L P4,510,072
12.6%
-16,210decrease
(-0.36%)
View
2023-02-14
12:05 pm
Purchase
13GIDEAYA Biosciences, Inc.
IDYA
BIOTECHNOLOGY VALUE FUND L P2,205,089
4.6%
240,230increase
(+12.23%)
View
2023-02-14
12:03 pm
Sale
13GGalmed Pharmaceuticals Ltd.
GLMD
BIOTECHNOLOGY VALUE FUND L P1,739,670
6.9%
-60,024decrease
(-3.34%)
View
2023-02-14
12:03 pm
Sale
13GMerus N.V.
MRUS
BIOTECHNOLOGY VALUE FUND L P2,978,420
6.4%
-1,156,651decrease
(-27.97%)
View
2023-02-14
12:00 pm
Sale
13G89bio, Inc.
ETNB
BIOTECHNOLOGY VALUE FUND L P3,521,126
6.5%
-376,874decrease
(-9.67%)
View
2023-02-14
12:00 pm
Purchase
13GPOINT Biopharma Global Inc.
PNT
BIOTECHNOLOGY VALUE FUND L P9,177,748
8.7%
3,587,700increase
(+64.18%)
View
2023-02-14
11:58 am
Sale
13GCrinetics Pharmaceuticals, Inc.
CRNX
BIOTECHNOLOGY VALUE FUND L P2,736,613
5.1%
-267,266decrease
(-8.90%)
View
2023-02-14
11:58 am
Sale
13GArcus Biosciences, Inc.
RCUS
BIOTECHNOLOGY VALUE FUND L P2,303,520
3.2%
-1,657,428decrease
(-41.84%)
View
2023-02-14
11:56 am
Sale
13GRelmada Therapeutics, Inc.
RLMD
BIOTECHNOLOGY VALUE FUND L P0
0%
-1,647,400decrease
(Position Closed)
View
2023-02-14
11:56 am
Sale
13GCogent Biosciences, Inc.
COGT
BIOTECHNOLOGY VALUE FUND L P984,824
1.4%
-2,129,708decrease
(-68.38%)
View
2023-02-14
11:53 am
Purchase
13GCullinan Oncology, Inc.
CGEM
BIOTECHNOLOGY VALUE FUND L P7,509,059
16.4%
2,139,600increase
(+39.85%)
View
2023-02-14
11:53 am
Sale
13GSyndax Pharmaceuticals, Inc.
SNDX
BIOTECHNOLOGY VALUE FUND L P1,451,197
2.1%
-3,480,682decrease
(-70.58%)
View
2023-02-14
11:50 am
Sale
13GCalliditas Therapeutics AB (publ)
CALT
BIOTECHNOLOGY VALUE FUND L P6,260,311
10.5%
-1,171,251decrease
(-15.76%)
View
Goto 0, 1, 2, ...18, 19, Next